Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-14

Clinical Trial Update: Alcoholism and Schizophrenia: Effects of Clozapine [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating clozapine for patients with schizophrenia and alcohol use disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOZARIL (Clozapine)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Schizophrenia, Dual Diagnosis | Phase 4 | Status: TERMINATED